Role of omalizumab in refractory chronic spontaneous urticaria: A single referral center experience

Role of omalizumab in refractory chronic spontaneous urticaria: A single referral center experience

Background: Multiple evidence have shown that omalizumab, a subcutaneous (SC) anti-IgE monoclonal antibody, is highly effective for the treatment of chronic spontaneous urticaria (CSU). Objective: The objective is to evaluate the safety and efficacy of omalizumab administered 300 mg SC 1st month fol...

Full description

Bibliographic Details
Main Authors: Gautam Kumar Singh, Manas Chatterjee, Rajesh Verma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Drugs in Dermatology
Subjects:
Chronic spontaneous urticaria
omalizumab
urticaria activity score 7
urticaria control test
Online Access:http://www.ijdd.in/article.asp?issn=2455-3972;year=2018;volume=4;issue=1;spage=18;epage=22;aulast=Singh

Internet

http://www.ijdd.in/article.asp?issn=2455-3972;year=2018;volume=4;issue=1;spage=18;epage=22;aulast=Singh

Similar Items